Skip to main content

Diabetes stocks jump as obesity-drug recovery comes ahead of schedule, analysts say

DexCom's strong quarterly results give device makers a boost.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.